Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...

The BBC is bringing audiences an unmissable summer of music in 2026, featuring live performances from some of the world’s ...

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...

Omeros Corporation announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company's marketing authorization ...

Sanofi (NASDAQ:SNY) said on Wednesday that it has decided to discontinue the phase 3 MOBILIZE trial evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) who ...

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose.

Get inspired to makeover your living spaces this year with these 100 incredible before and after home projects.

Filmmaker Imtiaz Ali's latest movie, 'Main Vaapas Aaunga,' features stunning outdoor settings, many of which are pre-existing ...

Time to get your systems in order, Aquarius. With the Sun in Cancer and your sixth house of health and routines until July 22—and Mercury retrograde here until the 23rd—you’ll be fine-tuning ...

Use this map to plan your route and discover just how close you are to this enchanting destination. So grab your camera, put ...

Sometimes the most magical places are the ones you’d never think to visit on purpose, and the Lexington Cemetery in Lexington ...